Session Details

F068 Botulinum Toxins: The Latest Updates

Mon, Mar 22, 9:00 AM - 11:00 AM
2 CME Available Forum

DESCRIPTION

Botulinum Toxin use has advanced significantly since its introduction in aesthetics. There are currently multiple decisions to be made regarding the type of BNTA products to be used, injection techniques, and indications. This forum aims to examine where we came from and what is new in understanding our clinical use of neuromodulators. We will present data on the similarities and differences in those drugs both available and soon to be available, as well as anatomy related to injections and new injection techniques. Reconstitution variations and psychosocial impacts on patients will also be highlighted.

LEARNING OBJECTIVES

1.

Discriminate between the various neuromodulators on the market

2.

Determine ideal injection techniques and anatomic safety zones to obtain the maximum efficacy

3.

Appreciate the objective and subjective outcomes of neuromodulator treatments on patients

DIRECTOR

Joely Kaufman, MD, FAAD

Joely Kaufman, MD, FAAD

SPEAKERS

Chytra V. Anand, MBBS, MSc, IFAAD

Chytra V. Anand, MBBS, MSc, IFAAD

Kosmoderma Helathcare and Academy

Doris M. Hexsel, MD, IFAAD

Doris M. Hexsel, MD, IFAAD

Hexsel Dermatologic Clinics - Private Clinics Rio de Janeiro and Porto Alegre, Brazil.

DISCLOSURES

Chytra V. Anand, MBBS, MSc, IFAAD

Allergan Aesthetics – Consultant (1099 relationship)(Fees); Alma Lasers – Speaker/Faculty Education(Fees); Jeisys – Consultant (1099 relationship)(Honoraria); Merz Aesthetics – Other(No Compensation Received); Revance Therapeutics, Inc. – Advisory Board(No Compensation Received);

Doris M. Hexsel, MD, IFAAD

Baiersdorf Eucerin – Speaker(Fees); Galderma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Rennova – Speaker(Fees);

Joely Kaufman, MD, FAAD

Allergan, Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Galderma USA – Advisory Board(Honoraria), Investigator(Fees); Jetema – Investigator(Grants/Research Funding); Johnson and Johnson – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); Neutrogena Corporation – Advisory Board(Honoraria); OneSkin – Consultant (1099 relationship)(Honoraria); Revance Therapeutics, Inc. – Investigator(Fees); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); TEOXANE Laboratories – Consultant (1099 relationship)(Fees), Investigator(Fees);